Multiparametric MRI Assessment of Atrial Heart Disease as a Predictor of Atrial Fibrillation After Myocardial Revascularization Surgery

Starting soon · Not applicable

Conditions studied: Postoperative Atrial Fibrillation

In brief

Postoperative atrial fibrillation (POAF) occurs in 20-40% of patients undergoing coronary artery bypass grafting (CABG) and is a marker of atrial vulnerability. It is strongly associated with AF recurrence, stroke, and cardiovascular mortality. It presents risk factors with atrial heart disease. The latter refers to all structural, electrical, and mechanical alterations of the atrium that create a substrate conducive to AF. Multiparametric cardiac MRI is currently the most comprehensive test for assessing atrial heart disease, thanks to its structural and functional analysis (atrial fibrosis, atrial strain, intracavitary 4D flow). However, to date, no prospective study has evaluated these parameters as predictors of AF recurrence after CAP. At the same time, an implantable Holter monitor will be used to enable detailed and continuous detection of recurrence episodes, overcoming the limitations of conventional monitoring strategies. By combining multiparametric imaging, histological analysis, and continuous monitoring for the first time, this study proposes a paradigm shift in the assessment of postoperative AF: moving from a descriptive and ad hoc approach to a mechanistic, integrative, and predictive approach.

Key facts

Study ID

NCT04657835

Run by

Centre Hospitalier Universitaire de Saint Etienne

People needed

100

Starts

2026-05-01

Expected to finish

2028-12-01

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Indication for surgical myocardial revascularization by isolated coronary artery bypass grafting, to be performed in the cardiac surgery department of Saint-Étienne University Hospital.
• Patient affiliated with or entitled to social security coverage
• Patient who has received informed information about the study and has co-signed, with the investigator, a consent form to participate in the study

You may not qualify if…

• Contraindication related to cardiac MRI
• Contraindication related to ILR implantation
• Documented history of atrial fibrillation
• Concomitant indication for valve surgery or other associated cardiac intervention
• Inability to understand French
• Patient refusal to participate in the study and/or inability to express consent or sign the informed consent form
• Patient subject to legal protection measures

Where it is running

• CHU Saint-Etienne — Saint-Etienne, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.